Hepatitis B reactivation after withdrawal of pre-emptive lamivudine in patients with haematological malignancy on completion of cytotoxic chemotherapy

Background: The hepatic outcome of hepatitis B surface antigen (HBsAg) positive patients undergoing chemotherapy after withdrawal of pre-emptive lamivudine is unknown. Aims: To examine the occurrence of hepatitis B virus (HBV) reactivation after withdrawal of pre-emptive lamivudine. Methods: Pre-emp...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Hui, C-K, Cheung, W W W, Au, W-Y, Lie, A K W, Zhang, H-Y, Yueng, Y-H, Wong, B C Y, Leung, N, Kwong, Y-L, Liang, R, Lau, G K K
Formato: Artigo
Lenguaje:Inglês
Publicado: Copyright 2005 by Gut 2005
Materias:
Hepatitis
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC1774754/
https://ncbi.nlm.nih.gov/pubmed/16000641
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/gut.2005.070763
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares